跳至主要内容
临床试验/NCT02196818
NCT02196818终止不适用

A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty

Medacta International SA4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
200
试验地点
4
主要终点
The Kaplan-Meier analysis as a measure of implant performance.

研究概览

简要总结

This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
  • Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
  • Patients must be willing to comply with the pre and post-operative evaluation schedule.

排除标准

  • Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.

结局指标

主要结局

The Kaplan-Meier analysis as a measure of implant performance.

时间窗: 5 years

次要结局

  • Radiological analysis as a meausure of safety.(3/6 months, 1,2 and 5 years)
  • The Harris Hip Score.(pre-op, 3/6 months, 1,2 and 5 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验